ORAGENICS INC
Biotechnology company developing intranasal therapeutics for neurological disorders.
OGEN | US
Overview
Corporate Details
- ISIN(s):
- US6840233026
- LEI:
- Country:
- United States of America
- Address:
- 1990 MAIN STREET, 34236 SARASOTA
- Website:
- https://www.oragenics.com/
Description
Oragenics, Inc. is a development-stage biotechnology company focused on developing therapeutics for neurological disorders. The company utilizes a proprietary intranasal delivery technology for targeted, non-invasive administration of pharmaceutical medications to the brain. Its lead candidate, ONP-002, is being developed as a potential treatment for concussion. The company's platform technology is also being explored for applications in other neurodegenerative diseases and central nervous system (CNS) disorders, with the goal of transforming patient care in neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ORAGENICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ORAGENICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ORAGENICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
